国際学会発表
1. Sato T, et al. Differences in Chronic Angioscopic Findings with Different Stent Types in Patientswith and without Diabetes Mellitus: Sub-analysis of a Report from Japanese Multicenter
Registry (MICASA). ACC 2017 (American College of Cardiology) 66th Annual Scientific
Session & Expo, 2017.March18 Washington DC, USA
2. Dai K, Sato T, Ishihara M, et al. Comparison of Chronic Angioscopic Findings ofBMS,1st-Generation DES and 2nd-Generation DES: A Report from Japanese Multicenter
Registry (MICASA) ACC (Ameican College of Cardiology) 2016 65th Annual Scientific
Session 2016.4.2. Chicago USA
3. Tanaka M, Sato T, et al: The J wave amplitude is attenuated in ischemic condition in patientswith stable coronary artery disease. 8th Asia pacific heart rhythm society scientific sessions
2015.11.19-22 Melbourne
4. Kashihara Y, Sato T, et al: Non-invasive estimation of the augmentation index at the central
aorta using cardiac magnetic resonance imaging. European Society of Cardiology Congress2014 (Spain) 8.30-9.3
5. Namba Y, Fuke S, Sato T, et al: Diagnostic accuracy of three different protocols for 3.0 T
coronary magnetic resonance angiography European Society of Cardiology Congress 2014
(Spain) 8.30-9.3
6. Fuke S, Sato T et al: Percutaneous coronary intervention immediately improves coronary
microcirculation function. European Society of Cardiology Congress 2014 (Spain) 8.30-9.3
7. Ono T, Fuke S, Sato T, et al: Coronary torsion contributes to edge late loss after
sirolimus-eluting stent and everolimus-eluting. European Society of Cardiology Congress 2014
(Spain) 8.30-9.3
8. Sato T, et al: In-hospital and long-term clinical outcomes of left main coronary artery disease inpatients with acute myocardial infarction 82nd European Atherosclerosis Society 2014.5.31-6.3
Madrid Spain
9. Sato T, et al: Five-year Clinical Outcomes after Implantation of Sirolimus-eluting Stent inPatients With and Without Diabetes Mellitus 10th International Congress on Coronary Artery
Disease 2013.10.13-16 (14), Florence, Italy
10. Tanaka M, Sato T, et al: A family of Long QT syndrome with the ECG characteristics provokedprominently in the response to brisk standing. Asian Pacific Heart Rhythm Society 2013.10.3-5(Hong Kong)
11. Sato T, et al: Comparison of the effects of nitroprusside versus nicorandil on slow/no-reflow
phenomenon during coronary interventions for acute myocardial infarction. 61st American
College of Cariology (ACC) annual scientific session March 24-27, 2012 Chicago, USA
12. Fuke S, Sato T, Ito H, et al: Difference in right ventricular adaptation to afterload between
patients with pulmonary hypertension in mild stage and patients with left-sided heart failureESC

8.27-31 Paris, 2011

13. Fuke S, Sato T, Ito H, et al: Assessment of right ventricular pulmpnary vascular coupling inpatients with chronic pulmonary hypertension AHA 11.13-17 Chicago, 2010
14. Sato T et al: Regional left ventricular Contractile Dynamics in Hypertrophic Cardiomyopathy
Estimated by Magnetic Resonance Imaging. 10th International Congress Cardiostim 96
European Journal of Cardiac Pacing and Electrophysiology June 19-22(21), Acropolis
Convention Center, Nice, France, 1996
15. Sato T et al: TRelationship between electrocardiographic features and distribution of
hypertrophy in hypertrophic cardiomyopathy. 3rd International Congress on Heart Failure May
21-25, Palexpo, Geneva, Switzerland, 1995
16. Sato T et al: Relationship between electrocardiographic features and distribution of hypertrophy
in hypertrophic cardiomyopathy. 67th American Heart Association (AHA) November 14-17,Dallas convention center, Dallas, Texas, USA. 1994

国内学会
学会長
第 25 回日本心血管インターベンション治療学会中国四国地方会 H30.9.2. 岡山

シンポジウム招待口演

1. 佐 藤 哲 也 ： 抗 血 栓 療 法 の 最 新 の 話 題

Real-world data を 中 心 に

Sapporo Live

Demonstration Course 2017 H29.9.1. 札幌
2. 佐藤哲也 ：ステントの観察 各種ステントの慢性期内視鏡所見に与える糖尿病の影響(MICASA サブ解析) 第 30 回日本心臓血管内視鏡学会 神戸 H28.10.1.
3. 佐藤哲也 ： ―PCI 治療における抗血小板剤療法―
急性心筋梗塞におけるプラスグレルの血小板凝集抑制効果と臨床的意義 第 38 回日本血栓止血学会 H28.6.16. 奈良
4. 佐藤哲也: これからの PCI にどの様な抗血小板剤が必要か？第 24 回日本心血管インターベンション治療学会 H27.7.30-8.1 福岡

この他座長、一般口演、ポスター発表（英語も含む）など合計約 200 回